ORBIMED ADVISORS LLC Q3 2016 Filing
Filed November 14, 2016
Portfolio Value
$8.8B
Holdings
136
Report Date
Q3 2016
Filing Type
13F-HR
All Holdings (136 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BIIBBIOGEN INC | 1,333,900 | $417.6B | 4755.25% | |
| 2 | BSXBOSTON SCIENTIFIC CORP | 17,211,700 | $409.6B | 4665.13% | |
| 3 | AMGNAMGEN INC | 2,436,700 | $406.5B | 4629.01% | |
| 4 | ALXNALEXION PHARMACEUTICALS INC | 2,638,011 | $323.3B | 3681.45% | |
| 5 | CELGCELGENE CORP | 2,948,577 | $308.2B | 3510.08% | |
| 6 | ABBVABBVIE INC | 4,229,900 | $266.8B | 3038.20% | |
| 7 | MRKMERCK & CO INC | 3,856,800 | $240.7B | 2741.26% | Call |
| 8 | —SHIRE PLC | 1,063,351 | $206.1B | 2347.62% | |
| 9 | —ALLERGAN PLC | 828,690 | $190.9B | 2173.55% | Call |
| 10 | ICPTUSDINTERCEPT PHARMACEUTICALS IN | 1,120,000 | $184.3B | 2099.35% | |
| 11 | LLYLILLY ELI & CO | 2,290,500 | $183.8B | 2093.60% | Call |
| 12 | —WRIGHT MED GROUP N V | 7,356,233 | $180.4B | 2055.02% | |
| 13 | AG8AGILENT TECHNOLOGIES INC | 3,714,800 | $174.9B | 1992.18% | |
| 14 | INCYINCYTE CORP | 1,850,178 | $174.5B | 1986.75% | |
| 15 | EWEDWARDS LIFESCIENCES CORP | 1,373,200 | $165.6B | 1885.39% | |
| 16 | PBYIPUMA BIOTECHNOLOGY INC | 2,383,525 | $159.8B | 1820.04% | |
| 17 | GILDGILEAD SCIENCES INC | 2,010,700 | $159.1B | 1811.75% | |
| 18 | IRWDIRONWOOD PHARMACEUTICALS INC | 9,949,000 | $158.0B | 1799.26% | |
| 19 | MOHMOLINA HEALTHCARE INC | 2,634,700 | $153.7B | 1749.90% | |
| 20 | WCGEURWELLCARE HEALTH PLANS INC | 1,248,000 | $146.1B | 1664.17% | |
| 21 | REGNREGENERON PHARMACEUTICALS | 355,300 | $142.8B | 1626.70% | |
| 22 | VRTXVERTEX PHARMACEUTICALS INC | 1,612,000 | $140.6B | 1601.02% | |
| 23 | ISRGINTUITIVE SURGICAL INC | 187,800 | $136.1B | 1550.23% | |
| 24 | TMOTHERMO FISHER SCIENTIFIC INC | 816,500 | $129.9B | 1479.04% | |
| 25 | BMYBRISTOL MYERS SQUIBB CO | 2,287,400 | $123.3B | 1404.61% | Call |
| 26 | PFEPFIZER INC | 3,532,200 | $119.6B | 1362.47% | |
| 27 | BMRNBIOMARIN PHARMACEUTICAL INC | 1,151,900 | $106.6B | 1213.71% | |
| 28 | —ACHILLION PHARMACEUTICALS IN | 13,107,200 | $106.2B | 1209.09% | |
| 29 | —EXPRESS SCRIPTS HLDG CO | 1,451,900 | $102.4B | 1166.21% | |
| 30 | JNJJOHNSON & JOHNSON | 858,000 | $101.4B | 1154.29% | |
| 31 | HCAHCA HOLDINGS INC | 1,312,200 | $99.2B | 1130.21% | |
| 32 | ARRYEURARRAY BIOPHARMA INC | 14,179,900 | $95.7B | 1090.03% | |
| 33 | ZBHZIMMER BIOMET HLDGS INC | 717,500 | $93.3B | 1062.42% | |
| 34 | NBIXNEUROCRINE BIOSCIENCES INC | 1,815,474 | $91.9B | 1047.01% | |
| 35 | ILMNILLUMINA INC | 495,500 | $90.0B | 1025.11% | |
| 36 | —IMPAX LABORATORIES INC | 3,787,500 | $89.8B | 1022.27% | |
| 37 | CRVSCORVUS PHARMACEUTICALS INC | 5,379,349 | $88.5B | 1007.76% | |
| 38 | UNHUNITEDHEALTH GROUP INC | 611,800 | $85.7B | 975.44% | |
| 39 | —AUDENTES THERAPEUTICS INC | 4,801,638 | $85.5B | 973.90% | |
| 40 | TEVATEVA PHARMACEUTICAL INDS LTD | 1,831,400 | $84.3B | 959.62% | |
| 41 | GKOSGLAUKOS CORP | 2,180,000 | $82.3B | 936.96% | |
| 42 | —MALLINCKRODT PUB LTD CO | 1,170,200 | $81.7B | 929.94% | |
| 43 | —BLUEBIRD BIO INC | 1,185,800 | $80.4B | 915.33% | |
| 44 | EX9EXELIXIS INC | 6,206,300 | $79.4B | 904.00% | |
| 45 | IM8NINSMED INC | 5,251,100 | $76.2B | 868.32% | |
| 46 | HUMHUMANA INC | 423,500 | $74.9B | 853.14% | |
| 47 | EGRXEAGLE PHARMACEUTICALS INC | 1,036,100 | $72.5B | 825.97% | |
| 48 | —ALLERGAN PLC | 88,200 | $72.5B | 825.15% | |
| 49 | MDTMEDTRONIC PLC | 766,600 | $66.2B | 754.30% | |
| 50 | INSYEURINSYS THERAPEUTICS INC NEW | 5,502,240 | $64.9B | 738.78% | |
| 51 | —OPHTHOTECH CORP | 1,166,200 | $53.8B | 612.66% | |
| 52 | NTLAINTELLIA THERAPEUTICS INC | 2,662,180 | $45.3B | 516.01% | |
| 53 | —LOXO ONCOLOGY INC | 1,728,000 | $45.2B | 515.20% | |
| 54 | THCTENET HEALTHCARE CORP | 1,993,000 | $45.2B | 514.31% | |
| 55 | COOCOOPER COS INC | 250,100 | $44.8B | 510.58% | |
| 56 | ASNDASCENDIS PHARMA A S | 2,191,000 | $44.0B | 501.53% | |
| 57 | —DIMENSION THERAPEUTICS INC | 5,397,698 | $43.1B | 491.16% | |
| 58 | CICIGNA CORPORATION | 325,700 | $42.4B | 483.38% | |
| 59 | VRAYQVIEWRAY INC | 9,127,990 | $41.3B | 469.88% | |
| 60 | —MAGELLAN HEALTH INC | 699,700 | $37.6B | 428.15% | |
| 61 | OTICEUROTONOMY INC | 1,850,094 | $33.7B | 383.25% | |
| 62 | —SYNERGY PHARMACEUTICALS DEL | 5,976,648 | $32.9B | 375.03% | |
| 63 | AERIEURAERIE PHARMACEUTICALS INC | 797,100 | $30.1B | 342.60% | |
| 64 | JAZZJAZZ PHARMACEUTICALS PLC | 246,900 | $30.0B | 341.57% | |
| 65 | GLPGGALAPAGOS NV | 457,900 | $29.6B | 337.19% | |
| 66 | —NEWLINK GENETICS CORP | 1,938,300 | $29.1B | 331.55% | |
| 67 | —LION BIOTECHNOLOGIES INC | 3,382,900 | $27.8B | 317.07% | |
| 68 | SELBUSDSELECTA BIOSCIENCES INC | 1,842,797 | $26.3B | 299.06% | |
| 69 | —IMMUNOMEDICS INC | 30,000,000 | $25.5B | 290.17% | |
| 70 | SYKSTRYKER CORP | 212,000 | $24.7B | 281.06% | |
| 71 | EXASEXACT SCIENCES CORP | 1,101,600 | $20.5B | 232.97% | |
| 72 | EHTHEHEALTH INC | 1,815,000 | $20.3B | 231.71% | |
| 73 | —CYNAPSUS THERAPEUTICS INC | 499,999 | $20.1B | 229.07% | |
| 74 | ABTABBOTT LABS | 440,500 | $18.6B | 212.16% | |
| 75 | XNCRXENCOR INC | 744,522 | $18.2B | 207.65% | |
| 76 | CHRSCOHERUS BIOSCIENCES INC | 671,600 | $18.0B | 204.82% | |
| 77 | —INOTEK PHARMACEUTICALS CORP | 1,849,300 | $17.5B | 199.65% | |
| 78 | —FORWARD PHARMA A/S | 798,000 | $16.8B | 190.76% | |
| 79 | IMGNEURIMMUNOGEN INC | 6,095,647 | $16.3B | 186.04% | |
| 80 | SRPTSAREPTA THERAPEUTICS INC | 261,800 | $16.1B | 183.09% | |
| 81 | ARWRARROWHEAD PHARMACEUTICALS IN | 2,159,973 | $15.9B | 180.80% | |
| 82 | SVASINOVAC BIOTECH LTD | 2,667,500 | $15.7B | 179.23% | |
| 83 | PRQRPROQR THRAPEUTICS N V | 2,305,446 | $15.4B | 175.12% | |
| 84 | —DERMIRA INC | 425,600 | $14.4B | 163.93% | |
| 85 | NTRANATERA INC | 1,276,190 | $14.2B | 161.47% | |
| 86 | FLBFLUIDIGM CORP DEL | 1,746,100 | $14.0B | 159.28% | |
| 87 | —AETNA INC NEW | 116,600 | $13.5B | 153.30% | |
| 88 | PIRSPIERIS PHARMACEUTICALS INC | 7,259,620 | $13.3B | 151.09% | |
| 89 | BCRUSDBARD C R INC | 58,000 | $13.0B | 148.14% | |
| 90 | —DBV TECHNOLOGIES S A | 345,700 | $12.6B | 143.03% | |
| 91 | VNDAVANDA PHARMACEUTICALS INC | 750,000 | $12.5B | 142.13% | Call |
| 92 | —IMMUNOMEDICS INC | 3,802,000 | $12.4B | 140.73% | |
| 93 | RAREULTRAGENYX PHARMACEUTICAL IN | 169,300 | $12.0B | 136.78% | |
| 94 | SNDXSYNDAX PHARMACEUTICALS INC | 757,365 | $11.5B | 130.76% | |
| 95 | —STEADYMED LTD | 3,072,196 | $11.0B | 125.60% | |
| 96 | SG7SAGE THERAPEUTICS INC | 235,400 | $10.8B | 123.45% | |
| 97 | ASMBASSEMBLY BIOSCIENCES INC | 1,397,100 | $10.1B | 114.72% | |
| 98 | —INOTEK PHARMACEUTICALS CORP | 7,000,000 | $9.5B | 108.73% | |
| 99 | —AFFIMED N V | 3,375,000 | $9.4B | 106.86% | |
| 100 | —NABRIVA THERAPEUTICS AG | 1,315,000 | $9.3B | 105.58% |
Page 1 of 2Next